# A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism

> **NCT07377474** · NA · NOT_YET_RECRUITING · sponsor: **Bausch & Lomb Incorporated** · enrollment: 32 (estimated)

## Conditions studied

- Myopic Astigmatism

## Interventions

- **DEVICE:** TENEO 317 Model 2 (1.28 US) Excimer Laser

## Key facts

- **NCT ID:** NCT07377474
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07377474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07377474, "A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07377474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*